The field of neural repair in stroke has identified cellular systems of reorganization and possible molecular mechanisms. Conceptual barriers now limit the generation of clinically useful agents. First, it is not clear what the causal mechanisms of neural repair are in stroke. Second, adequate delivery systems for neural repair drugs need to be determined for candidate molecules. Third, ad hoc applications of existing pharmacological agents that enhance attention, mood or arousal to stroke have failed. New approaches that specifically harness the molecular systems of learning and memory provide a new avenue for stroke repair drugs. Fourth, combinatorial treatments for neural repair need to be considered for clinical therapies. Finally, neural repair therapies have as a goal altering brain connections, cognitive maps and active neural networks. These actions may trigger a unique set of "neural repair side effects" that need to be considered in planning clinical trials.
qIf a rule prevents you from improving or maintaining Wikipedia, ignore it.q http://en.wikipedia.org/wiki/Wikipedia:Ignore_all_rules Neural repair started as a field that ignored the rules. The rules consisted of certified CNS dogma about the static nature of brain structure and connectivity. Examples include the rule that the adult brain formed new connections only in certain specialized and highly plastic structures, such as the hippocampus; or, that regions of the adult brain did not develop new populations of neurons. Early studies in neural repair after stroke suggested that growth-associated proteins commonly linked to axonal growth cones were induced in humans and animals in peri-infarct tissue (Ng et al., 1988; Stroemer et al., 1995) . Later studies extended these findings with quantitative analysis of axonal connections to show that the adult brain forms new connections in peri-infarct cortex, and in projections from cortex opposite to the stroke (Carmichael et al., 2001; Chen et al., 2002; Dancause et al., 2005) . Later studies in neural repair suggested a fantastic biology-that not only was the "no new neuron" dogma wrong, but stroke signaled for a long distance migration of newly born neurons through several different CNS tissue compartments to regions of damage after injury (Arvidsson et al., 2002; Parent et al., 2002; Zhang et al., 2004; Ohab et al., 2006) . On closer examination of the literature, these "rules" on static CNS structure were actually more commonly accepted beliefs. Evidence has been present for some time that synaptogenesis or cortical growth occurs in the adult as a result of activity and injury (Eccles, 1976; Kolb et al., 1983; Greenough et al., 1985) . Neurogenesis in the olfactory and hippocampal systems in normal and injured states was well described for some time before its expansion was recognized in stroke (Altman and Das, 1965; Reznikov, 1975; Kaplan and Hinds, 1977) . The key evolution in this field is the recognition that these structural changes may underlie at least a component of functional recovery, and may 
